Thomas Boyer Laboratoire d’hématologie CHU Lille Biography Publications Institution JoVE Articles Thomas Boyer has not added a biography. If you are Thomas Boyer and would like to personalize this page please email our Author Liaison for assistance. Publications Detection of a New Heterozygous Germline ETV6 Mutation in a Case with Hyperdiploid Acute Lymphoblastic Leukemia European Journal of Haematology. Jan, 2018 | Pubmed ID: 29034503 Tetraspanin CD81 is an Adverse Prognostic Marker in Acute Myeloid Leukemia Oncotarget. 09, 2016 | Pubmed ID: 27566555 Acquisition of Genomic Events Leading to Lymphoblastic Transformation in a Rare Case of Myeloproliferative Neoplasm with BCR-JAK2 Fusion Transcript European Journal of Haematology. Oct, 2016 | Pubmed ID: 26935241 NUP214-ABL1 Fusion Defines a Rare Subtype of B-cell Precursor Acute Lymphoblastic Leukemia That Could Benefit from Tyrosine Kinase Inhibitors Haematologica. Apr, 2016 | Pubmed ID: 26681761 Paroxysmal Nocturnal Hemoglobinuria (PNH) and T Cell Large Granular Lymphocyte (LGL) Leukemia--an Unusual Association: Another Cause of Cytopenia in PNH Annals of Hematology. Oct, 2015 | Pubmed ID: 26152552 Citometría de flujo para estimar las células madre de leucemia la leucemia mieloide aguda primaria y el paciente-derivado-xenoinjertos, diagnóstico y seguimiento hasta Thomas Boyer1,2, Fanny Gonzales2,3, Adriana Plesa4, Pauline Peyrouze2, Adeline Barthelemy2, Soizic Guihard2, Bruno Quesnel2,5, Christophe Roumier1,2, Claude Preudhomme1,2, Meyling Cheok2 1Laboratoire d’hématologie, CHU Lille, 2Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - JPArc - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer, 3Service d’hématologie pédiatrique, hôpital Jeanne de Flandre, CHU Lille, 4Laboratoire d’hématologie CH Lyon Sud, 5Service des Maladies du Sang, hôpital Claude Huriez, CHU Lille JoVE 56976 Investigación sobre el cáncer
Citometría de flujo para estimar las células madre de leucemia la leucemia mieloide aguda primaria y el paciente-derivado-xenoinjertos, diagnóstico y seguimiento hasta Thomas Boyer1,2, Fanny Gonzales2,3, Adriana Plesa4, Pauline Peyrouze2, Adeline Barthelemy2, Soizic Guihard2, Bruno Quesnel2,5, Christophe Roumier1,2, Claude Preudhomme1,2, Meyling Cheok2 1Laboratoire d’hématologie, CHU Lille, 2Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - JPArc - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer, 3Service d’hématologie pédiatrique, hôpital Jeanne de Flandre, CHU Lille, 4Laboratoire d’hématologie CH Lyon Sud, 5Service des Maladies du Sang, hôpital Claude Huriez, CHU Lille JoVE 56976 Investigación sobre el cáncer
